Trial Profile
ST-605 uncontrolled open-label phase 2 study in patients with herpes simplex virus keratitis
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 11 Dec 2018
Price :
$35
*
At a glance
- Drugs Ganciclovir (Primary)
- Indications Dendritic keratitis
- Focus Therapeutic Use
- Sponsors Ms Science
- 11 Dec 2018 New trial record